Pedro de Godoy Bueno has been CEO of Grupo Diagnósticos da América (Dasa) since 2015. He has integrated the brands of the laboratory chain and the hospital group, which is expanding through acquisitions amid consolidation in the healthcare sector. Dasa is considered the fifth largest diagnostic medicine company in the world, owning brands such as Delboni Auriemo, Sérgio Franco, Bronstein and Lavoisier. He holds a degree in economics from PUC-Rio and has worked at Credit Suisse and BTG Pactual banks.
